Literature DB >> 22348512

The feasibility of antibiotic dosing four times per day: a prospective observational study in primary health care.

Torunn Bjerve Eide1, Veslemøy Cathrine Hippe, Mette Brekke.   

Abstract

OBJECTIVE: To investigate whether the increase in the number of doses of penicillin V from three times daily to four times daily for common infections, as recommended in the new Norwegian guidelines for antibiotic treatment in primary health care, would lead to reduced patient compliance.
DESIGN: Prospective observational study. SETTING AND
SUBJECTS: Six general practitioners included all patients who were prescribed systemic antibiotic treatment regardless of indication during a 10-month period. A total of 270 patients provided data for the study.
METHODS: Telephone interview focusing on omitted antibiotic doses.
RESULTS: Some 17% of patients had poor compliance, defined as failing to take 5% or more of total antibiotic doses. Neither level of poor compliance nor number of omitted doses differed significantly when the number of daily doses increased from three to four. There were significantly fewer omitted doses in the group given two doses per day when compared with three doses (p = 0.04) and four doses per day (p = 0.01).
CONCLUSION: We found no difference in compliance or omitted doses between antibiotic regimens of three and four doses per day. The new Norwegian guidelines for antibiotic treatment in primary health care appear feasible with regard to patient compliance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22348512      PMCID: PMC3337524          DOI: 10.3109/02813432.2012.654196

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  12 in total

Review 1.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

2.  [We must be better in antibiotics dosing].

Authors:  E Arne Høiby; Rolf A Walstad
Journal:  Tidsskr Nor Laegeforen       Date:  2008-12-04

Review 3.  [New guidelines for antibiotic use in primary health care].

Authors:  Knut Eirik Eliassen; Arne Fetveit; Per Hjortdahl; Dag Berild; Morten Lindbaek
Journal:  Tidsskr Nor Laegeforen       Date:  2008-10-23

Review 4.  A review of the factors associated with patient compliance and the taking of prescribed medicines.

Authors:  S Griffith
Journal:  Br J Gen Pract       Date:  1990-03       Impact factor: 5.386

Review 5.  Patient compliance with antibiotic treatment for respiratory tract infections.

Authors:  Przemyslaw Kardas
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

Review 6.  Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

Authors:  W A Craig
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

7.  Dose timing and patient compliance with two antibiotic treatment regimens for lower respiratory tract infections in primary care.

Authors:  Jochen W L Cals; Rogier M Hopstaken; Philippe H A Le Doux; Ger A Driessen; Patricia J Nelemans; Geert-Jan Dinant
Journal:  Int J Antimicrob Agents       Date:  2008-05-05       Impact factor: 5.283

8.  [Antibiotic use in Norway].

Authors:  Irene Litleskare; Hege Salvesen Blix; Marit Rønning
Journal:  Tidsskr Nor Laegeforen       Date:  2008-10-23

9.  The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance.

Authors:  Carl Llor; Nuria Sierra; Silvia Hernández; Ana Moragas; Marta Hernández; Carolina Bayona; Marc Miravitlles
Journal:  J Antimicrob Chemother       Date:  2008-11-16       Impact factor: 5.790

Review 10.  Benefits of statin therapy and compliance in high risk cardiovascular patients.

Authors:  Joel A Lardizabal; Prakash C Deedwania
Journal:  Vasc Health Risk Manag       Date:  2010-10-05
View more
  2 in total

1.  A randomized controlled study of 5 and 10 days treatment with phenoxymethylpenicillin for pharyngotonsillitis caused by streptococcus group A - a protocol study.

Authors:  Gunilla Skoog; Charlotta Edlund; Christian G Giske; Sigvard Mölstad; Christer Norman; Pär-Daniel Sundvall; Katarina Hedin
Journal:  BMC Infect Dis       Date:  2016-09-13       Impact factor: 3.090

2.  Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study.

Authors:  Gunilla Skoog Ståhlgren; Mia Tyrstrup; Charlotta Edlund; Christian G Giske; Sigvard Mölstad; Christer Norman; Karin Rystedt; Pär-Daniel Sundvall; Katarina Hedin
Journal:  BMJ       Date:  2019-10-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.